Published in Thorax on March 01, 2006
Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD (RECUT) | NCT02386735
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest (2008) 2.24
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 1.72
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. Eur Respir J (2011) 1.68
RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism. Am J Respir Crit Care Med (2011) 1.49
Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS One (2013) 1.43
Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J Cell Mol Med (2012) 1.42
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respir Res (2010) 1.21
Virus-induced exacerbations in asthma and COPD. Front Microbiol (2013) 1.04
Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 1.04
Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc (2011) 1.00
What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines. Thorax (2007) 0.98
The role of toll-like receptors in acute and chronic lung inflammation. J Inflamm (Lond) (2010) 0.97
Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells. Infect Immun (2011) 0.96
A clonal group of nontypeable Haemophilus influenzae with two IgA proteases is adapted to infection in chronic obstructive pulmonary disease. PLoS One (2011) 0.95
Oxidative stress enhances toll-like receptor 3 response to double-stranded RNA in airway epithelial cells. Am J Respir Cell Mol Biol (2009) 0.93
The Saudi Guidelines for the Diagnosis and Management of COPD. Ann Thorac Med (2014) 0.92
Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A. Am J Pathol (2011) 0.90
Inflammatory biomarkers in sputum predict COPD exacerbations. Lung (2013) 0.90
Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.87
Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling. J Immunol (2013) 0.86
Metabolic spectroscopy of inflammation in a bleomycin-induced lung injury model using hyperpolarized 1-(13) C pyruvate. NMR Biomed (2014) 0.83
Identifying viral infections in vaccinated Chronic Obstructive Pulmonary Disease (COPD) patients using clinical features and inflammatory markers. Influenza Other Respir Viruses (2010) 0.83
Acute mechanical forces cause deterioration in lung structure and function in elastase-induced emphysema. Am J Physiol Lung Cell Mol Physiol (2012) 0.83
Oral non-typable Haemophilus influenzae enhances physiological mechanism of airways protection. Clin Exp Immunol (2010) 0.83
Acute respiratory and cardiovascular admissions after a public smoking ban in Geneva, Switzerland. PLoS One (2014) 0.82
Oxidative stress and inflammation are differentially affected by atorvastatin, pravastatin, rosuvastatin, and simvastatin on lungs from mice exposed to cigarette smoke. Inflammation (2014) 0.81
Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study. Clin Drug Investig (2013) 0.81
Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis (2014) 0.81
Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Aeroparticles, Composition, and Lung Diseases. Front Immunol (2016) 0.80
Analysis of the bacterial community in chronic obstructive pulmonary disease sputum samples by denaturing gradient gel electrophoresis and real-time PCR. BMC Pulm Med (2014) 0.80
Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc (2015) 0.80
The Influence of Asian Dust, Haze, Mist, and Fog on Hospital Visits for Airway Diseases. Tuberc Respir Dis (Seoul) (2015) 0.79
25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells. Respir Res (2012) 0.79
Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism. Thorax (2007) 0.78
Plasma proteomic profile of sulfur mustard exposed lung diseases patients using 2-dimensional gel electrophoresis. Clin Proteomics (2011) 0.78
Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med (2014) 0.78
The prevalence of pulmonary embolism among patients suffering from acute exacerbations of chronic obstructive pulmonary disease. Emerg Radiol (2014) 0.78
Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist. Respir Res (2015) 0.78
Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection. Respir Res (2016) 0.77
Probiotics in the management of lung diseases. Mediators Inflamm (2013) 0.77
Serum amyloid alpha in parapneumonic effusions. Mediators Inflamm (2011) 0.77
Mental health, serum biomarkers and survival in severe COPD: a pilot study. Multidiscip Respir Med (2016) 0.77
Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients. Int J Chron Obstruct Pulmon Dis (2007) 0.77
The influence of virus infections on the course of COPD. Eur J Microbiol Immunol (Bp) (2012) 0.77
JTD special edition 'Hot Topics in COPD'-The microbiome in COPD. J Thorac Dis (2014) 0.77
Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Fam Pract (2015) 0.76
Incidence of pulmonary embolism during COPD exacerbation. J Bras Pneumol (2014) 0.76
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review. Respir Res (2016) 0.76
Severe hypoalbuminemia is a strong independent risk factor for acute respiratory failure in COPD: a nationwide cohort study. Int J Chron Obstruct Pulmon Dis (2015) 0.76
Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland. Int J Chron Obstruct Pulmon Dis (2013) 0.76
Small pulmonary vascular alteration and acute exacerbations of COPD: quantitative computed tomography analysis. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Tiotropium Attenuates Virus-Induced Pulmonary Inflammation in Cigarette Smoke-Exposed Mice. J Pharmacol Exp Ther (2016) 0.75
Effects of corticosteroid plus long-acting beta2-agonist on the expression of PD-L1 in double-stranded RNA-induced lung inflammation in mice. J Inflamm (Lond) (2017) 0.75
Impaired Blood Neutrophil Function in the Frequent Exacerbator of Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study. Lung (2016) 0.75
Hypoxia-induced pulmonary arterial hypertension augments lung injury and airway reactivity caused by ozone exposure. Toxicol Appl Pharmacol (2016) 0.75
The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells. J Clin Cell Immunol (2016) 0.75
Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke. Tanaffos (2012) 0.75
Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males. PLoS One (2016) 0.75
Optimizing bronchodilation in the prevention of COPD exacerbations. Respir Res (2017) 0.75
Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China. BMC Infect Dis (2017) 0.75
The Challenges of Precision Medicine in COPD. Mol Diagn Ther (2017) 0.75
Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism. Exp Ther Med (2017) 0.75
Bacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid. Int J Chron Obstruct Pulmon Dis (2017) 0.75
The Relationship between Airway Inflammation and Exacerbation in Chronic Obstructive Pulmonary Disease. Tuberc Respir Dis (Seoul) (2017) 0.75
An association between air pollution and mortality in six U.S. cities. N Engl J Med (1993) 38.84
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 10.05
Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med (2005) 9.47
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (1987) 8.41
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med (2002) 7.87
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Am J Respir Crit Care Med (1996) 5.82
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 5.49
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax (2000) 4.45
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax (2002) 4.26
Toward a consensus definition for COPD exacerbations. Chest (2000) 3.70
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev (2001) 3.58
Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 3.50
Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol (1997) 3.38
Health effects of particulate air pollution: time for reassessment? Environ Health Perspect (1995) 3.29
Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med (1994) 3.06
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 2.98
Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J (1999) 2.96
Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 2.96
Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis (2003) 2.91
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest (2003) 2.90
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.82
Do bacteria cause exacerbations of COPD? Chest (2000) 2.78
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med (2005) 2.61
Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro. Thorax (1996) 2.58
Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.52
Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax (1996) 2.52
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J (1999) 2.44
Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J (1997) 2.43
Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest (2000) 2.35
A VIROLOGIC STUDY OF CHRONIC BRONCHITIS. N Engl J Med (1964) 2.28
Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol (2005) 2.27
Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax (1997) 2.19
Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem (1999) 2.11
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08
Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol (2005) 2.05
Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J (2000) 2.00
Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.93
Neutrophils and the pathogenesis of COPD. Chest (2002) 1.89
Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med (2001) 1.88
Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.85
Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect (2005) 1.83
Effect of nitrogen dioxide and sulphur dioxide on airway response of mild asthmatic patients to allergen inhalation. Lancet (1994) 1.83
Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. Am J Epidemiol (1993) 1.81
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Exacerbations of chronic obstructive pulmonary disease. Respir Care (2003) 1.80
Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis (2001) 1.80
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med (1997) 1.79
Effect of bacterial products on human ciliary function in vitro. Thorax (1985) 1.78
Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am J Respir Crit Care Med (2000) 1.75
Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.73
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy (1996) 1.72
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J (2001) 1.67
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med (1998) 1.64
Infectious etiology of acute exacerbations of chronic bronchitis. Chest (2000) 1.63
Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax (2002) 1.59
Interaction of nontypable Haemophilus influenzae with human respiratory mucosa in vitro. J Infect Dis (1991) 1.59
Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med (2001) 1.55
Effect of the fine fraction of particulate matter versus the coarse mass and other pollutants on daily mortality in Santiago, Chile. J Air Waste Manag Assoc (2000) 1.55
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med (1999) 1.54
Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.53
Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest (1997) 1.52
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax (2002) 1.51
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax (2001) 1.48
Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J (1994) 1.41
Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest (1991) 1.38
Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med (1999) 1.37
Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med (2005) 1.34
Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis (1976) 1.33
The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis (1985) 1.31
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J (2005) 1.30
Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.30
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax (2001) 1.27
Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J (1999) 1.27
TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol (2005) 1.26
Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest (1995) 1.25
Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol (2000) 1.25
The heterogeneity of chronic obstructive pulmonary disease. Thorax (2000) 1.25
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax (2001) 1.21
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax (2003) 1.20
Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. J Immunol (1996) 1.20
Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur Respir J (2000) 1.19
Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J (2000) 1.17
Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Respir J (2003) 1.16
Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax (2003) 1.14
Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways. Am J Pathol (1986) 1.14
Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis (1980) 1.14
Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1991) 1.09
Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis (1990) 1.09
The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Radic Biol Med (1999) 1.08
A study of infective and other factors in exacerbations of chronic bronchitis. Br J Dis Chest (1980) 1.07
Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med (1996) 1.06
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J (2000) 1.04
Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med (2005) 1.03
Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J (1997) 1.01
Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1991) 1.00
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 2.12
Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax (1984) 2.07
Proteinuria with streptokinase. Lancet (1993) 2.01
Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax (2011) 1.89
Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax (1984) 1.82
A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis. Thorax (1979) 1.79
High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J (2001) 1.71
Alpha,-antitrypsin and leukocyte elastase in infected and noninfected sputum. Am Rev Respir Dis (1979) 1.69
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J (2001) 1.67
Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax (2000) 1.65
Rate of progression of lung function impairment in alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.61
COPD: current therapeutic interventions and future approaches. Eur Respir J (2005) 1.61
Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis. Thorax (2009) 1.55
Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax (2005) 1.55
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med (1999) 1.54
Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J (2000) 1.50
Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol (1991) 1.50
The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax (2010) 1.46
Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med (1999) 1.45
Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.41
Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis. J Antimicrob Chemother (1994) 1.39
Proteolytic enzymes, their inhibitors and lung diseases. Clin Sci (Lond) (1983) 1.35
The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J Biol Chem (1992) 1.32
Cathepsin B-like cysteine proteinase activity in sputum and immunohistologic identification of cathepsin B in alveolar macrophages. Am Rev Respir Dis (1983) 1.29
Leukotriene B4. Int J Biochem Cell Biol (1998) 1.28
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax (2001) 1.27
Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Thorax (2006) 1.24
Predictors of mortality in alpha1-antitrypsin deficiency. Thorax (2003) 1.24
Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med (2001) 1.24
Why do patients develop reactions to streptokinase? Clin Exp Immunol (1993) 1.23
Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis. Eur J Respir Dis (1984) 1.22
Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci (Lond) (1987) 1.22
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax (2003) 1.20
Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur Respir J (2000) 1.19
Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax (1986) 1.19
Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med (1996) 1.19
Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax (2002) 1.16
Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet (1987) 1.15
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax (2004) 1.15
Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease. Thorax (1982) 1.15
Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax (2003) 1.14
Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol (1995) 1.13
Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state. Thorax (1984) 1.13
Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection. Bull Eur Physiopathol Respir (1980) 1.12
Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax (2002) 1.11
Measurement of soluble proteins in lung secretions. Thorax (1984) 1.10
Proteolytic enzymes and airway diseases. Eur Respir J (1998) 1.08
A discrete subpopulation of human monocytes expresses a neutrophil-like proinflammatory (P) phenotype. Am J Physiol (1994) 1.08
The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med (1998) 1.06
Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med (2001) 1.05
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J (2000) 1.04
The immunological measurements of 'free' secretory piece and its relationship to local IgA production. Clin Exp Immunol (1981) 1.04
Assessment of 7S and 11S immunoglobulin A in sputum. Am Rev Respir Dis (1980) 1.04
alpha-1-Antitrypsin and the pathogenesis of emphysema. Lung (1987) 1.04
Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale. Thorax (1977) 1.03
Variability in sputum sol phase proteins in chronic obstructive bronchitis. The value of using albumin for standardization. Am Rev Respir Dis (1983) 1.02
Smoke exposure as a determinant of autoantibody titre in α₁-antitrypsin deficiency and COPD. Eur Respir J (2010) 1.02
Local IgA production in patients with chronic bronchitis: effect of acute respiratory infection. Thorax (1980) 1.01
Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax (2007) 1.01
The immunological assessment of alpha 1-antitrypsin with reference to its function in bronchial secretions. Clin Sci (Lond) (1983) 1.01
A case of Haemophilus parainfluenzae pneumonia. Thorax (2000) 1.00
IgG subclasses in the serum and sputum from patients with bronchiectasis. Thorax (1998) 0.99
The significance of anti-streptokinase antibodies. Clin Exp Immunol (1994) 0.99
Quality of life in elderly subjects with a diagnostic label of asthma from general practice registers. Eur Respir J (1999) 0.99
Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis. Thorax (2001) 0.99
Activities and sources of beta-lactamase in sputum from patients with bronchiectasis. J Clin Microbiol (1989) 0.98
The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem (1995) 0.98
A method for the study of local IgA production using radial immunodiffusion and thin layer chromatography. J Immunol Methods (1980) 0.97
Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment. Clin Sci (Lond) (1985) 0.97
Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease. Thorax (1981) 0.96
Chemotactic activity of urethral secretions in men with urethritis and the effect of treatment. J Infect Dis (1993) 0.96
Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions. Thorax (1986) 0.96
An evaluation of four methods for the measurement of elastase activity. Clin Chim Acta (1981) 0.95
Nebulized amoxicillin in chronic purulent bronchiectasis. Clin Ther (1985) 0.95
The assessment of alpha 1 proteinase inhibitor form and function in lung lavage fluid from healthy subjects. Biol Chem Hoppe Seyler (1988) 0.94
The effect of the Z mutation on the ability of alpha 1-antitrypsin to prevent neutrophil mediated tissue damage. Biochim Biophys Acta (1994) 0.93
Interaction between leukocyte elastase and elastin: quantitative and catalytic analyses. Biochim Biophys Acta (1999) 0.92
Monocyte adherence to fibronectin: role of CD11/CD18 integrins and relationship to other monocyte functions. J Leukoc Biol (1992) 0.91
The effect of in vitro and in vivo dexamethasone on human neutrophil function. Agents Actions (1991) 0.91
The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax (2002) 0.90
Validation of assays for inflammatory mediators in exhaled breath condensate. Eur Respir J (2008) 0.90
Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity. Am J Respir Cell Mol Biol (1990) 0.90
Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis Markers (1991) 0.89
Animal models of chronic obstructive pulmonary disease. Thorax (2001) 0.89
Inflammation--role of the neutrophil and the eosinophil. Semin Respir Infect (2000) 0.88
Lung secretion sol-phase proteins: comparison of sputum with secretions obtained by direct sampling. Thorax (1983) 0.88
Relationship of neutrophil cytoplasmic protein (L1) to acute and chronic lung disease. Scand J Clin Lab Invest (1984) 0.88
The many uses of bronchoalveolar lavage. Br Med J (Clin Res Ed) (1988) 0.88
Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids. Eur Respir J (2008) 0.87
The electrophoretic mobility of alpha 1-antitrypsin in sputum and its relationship to protease inhibitory capacity, leucocyte elastase concentrations and acute respiratory infection. Hoppe Seylers Z Physiol Chem (1980) 0.87
Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage. Hoppe Seylers Z Physiol Chem (1984) 0.87
Birmingham Medical Research Expeditionary Society 1977 Expedition: cardiopulmonary function before, during and after a twenty-one-day Himalayan trek. Postgrad Med J (1979) 0.87
Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples. Thorax (1986) 0.86
The distribution of antibodies to streptokinase. Postgrad Med J (1996) 0.86
Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase. Clin Sci (Lond) (1987) 0.86
Early effects of intravenous terbutaline on cardiopulmonary function in chronic obstructive bronchitis and pulmonary hypertension. Thorax (1982) 0.86
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. Eur Respir J (2002) 0.86
Evidence that alveolar macrophages can synthesize and secrete alpha 1-antichymotrypsin. Am Rev Respir Dis (1984) 0.86
Effect of storage and postage on recovery and quantitation of bacteria in sputum samples. J Clin Pathol (2007) 0.86